Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
about
Genome-wide analysis of microRNA and mRNA expression signatures in cancerDatabase integration of 4923 publicly-available samples of breast cancer molecular and clinical data.Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarrayBiomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis.Evidence for the importance of personalized molecular profiling in pancreatic cancer.High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancerPrediction of breast cancer metastasis by gene expression profiles: a comparison of metagenes and single genes.A transcriptional and metabolic signature of primary aneuploidy is present in chromosomally unstable cancer cells and informs clinical prognosisMembrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5.A high level of TM4SF5 is associated with human esophageal cancer progression and poor patient survival.Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.Predicting patient survival from longitudinal gene expression.Expression profiling of breast tumors based on human epidermal growth factor receptor 2 status defines migration-related genes.Gene expression profiles for predicting metastasis in breast cancer: a cross-study comparison of classification methods.Caveats and pitfalls of ROC analysis in clinical microarray research (and how to avoid them)
P2860
Q26795603-586A922E-D8AA-4BCF-B9E3-C3D7008E57C2Q30707752-471DF279-4A63-46A7-B792-F0E05204D988Q33606254-4ACA678E-ABC7-49BC-A0E3-CCCF61676D26Q34385125-55702B7E-529A-436C-96D8-2A3887F36F3CQ34387784-C1108EC9-2848-4B55-A3AC-3478C05DD921Q34572152-07361FEF-F694-453E-B131-9B64A8EF1568Q36486836-59F77A5A-9CA7-4240-A3ED-9A173A3D62C0Q37513855-2F3A4016-14CF-4B0A-9312-8F7B0A20B7B5Q37709042-A4E50954-5DF5-40C8-928E-93ACB3EE5048Q39158038-E458226A-0FDD-4A3E-966B-AE4757336AB6Q39532008-D11B06F2-F6F8-46E6-A989-D0EBFABA04ECQ39810530-452E9E48-C8D2-4ED6-BE6F-97C2887098CFQ44174588-25730F71-FCC9-4D51-BC0F-119914CC5665Q51286532-5BE75792-4D9B-46A4-9A41-DAFE697FD244Q58642712-1CD52CE6-3AD0-4941-881C-7FF0F0C9E977
P2860
Gene expression variation to predict 10-year survival in lymph-node-negative breast cancer.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Gene expression variation to p ...... h-node-negative breast cancer.
@ast
Gene expression variation to p ...... h-node-negative breast cancer.
@en
type
label
Gene expression variation to p ...... h-node-negative breast cancer.
@ast
Gene expression variation to p ...... h-node-negative breast cancer.
@en
prefLabel
Gene expression variation to p ...... h-node-negative breast cancer.
@ast
Gene expression variation to p ...... h-node-negative breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Gene expression variation to p ...... h-node-negative breast cancer.
@en
P2093
Elin Karlsson
Frida Abel
Khalil Helou
Per Karlsson
Ulla Delle
P2860
P2888
P356
10.1186/1471-2407-8-254
P407
P577
2008-09-08T00:00:00Z
P5875
P6179
1030373141